A Barn Raising Column: Tell Me What You Think As we shift more into a mode where we interview...
Author Archive for: support@thriveagency.com
A Brief Update on Sorrento ($SRNE) Was a time when novelists garnered add-on Warholian 15-minute clumps of fame by...
An Exceptionally Difficult Madcap Multi Part Question of the Day
support@thriveagency.com, , BioPub, sample, 0AN EXCEPTIONALLY DIFFICULT, MADCAP, MULTI-PART QUESTION OF THE DAY “The disease of the Lady Madeline had long baffled the...
Checking in with Aptose Biosciences ($APTO) CEO Dr. William Rice
support@thriveagency.com, , BioPub, sample, 0Ten Common Biotech Investing Mistakes Aptose CEO Rice (R) with CEO Joo Jung-myeong of Crystal Genomics, Seoul, 2018. A milestone...
Inovio CEO Dr. Joseph Kim Pops By The Pub LONDON–Life charmingly imitated art last night, as London’s unexpected cold...
Oncolytics Makes Good on Promise Brings New Tumor Response Biomarker to Clinic
support@thriveagency.com, , BioPub, sample, 0Oncolytics Makes Good on Promise Brings New Tumor Response Biomarker to Clinic Oncolytics ($ONCY) CMO Rita Laeufle, MB, BCh...
Sweet Bird of Youth: Talking with Chromadex ($CDXC) Co-Founder and Chairman Frank Jaksch
support@thriveagency.com, , BioPub, sample, 0Sweet Bird of Youth: Talking with Chromadex ($CDXC) Co-Founder and Chairman Frank Jaksch by KSS, MD, PhD, and Allan...
Ten Common Biotech Investing Mistakes Assessing biotechnology stocks involves use of lots of mental microscopes and magnifying lenses. But...
The Pleasure of Meeting Interim Cohbar CEO Dr. Philippe Calais
support@thriveagency.com, , BioPub, sample, 0The Pleasure of Meeting Interim Cohbar CEO Dr. Philippe Calais Philippe CALAIS, Pharm.D., Ph.D. Dr. Philippe Calais is something...